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ABSTRACT
Mass spectrometry (MS)-based proteomics has
become a powerful technology to map the protein
composition of organelles, cell types and tissues. In
our department, a large-scale effort to map these
proteomes is complemented by the Max-Planck
Unified (MAPU) proteome database. MAPU contains
several body fluid proteomes; including plasma,
urine, and cerebrospinal fluid. Cell lines have been
mapped to a depth of several thousand proteins and
the red blood cell proteome has also been analyzed
in depth. The liver proteome is represented with
3200 proteins. By employing high resolution MS and
stringent validation criteria, false positive identifica-
tion rates in MAPU are lower than 1:1000. Thus
MAPU datasets can serve as reference proteomes
in biomarker discovery. MAPU contains the peptides
identifying each protein, measured masses, scores
and intensities and is freely available at http://www.
mapuproteome.com using a clickable interface of
cell or body parts. Proteome data can be queried
across proteomes by protein name, accession
number, sequence similarity, peptide sequence
and annotation information. More than 4500 mouse
and 2500 human proteins have already been identi-
fied in at least one proteome. Basic annotation
information and links to other public databases are
provided in MAPU and we plan to add further
analysis tools.
INTRODUCTION
The availability of genome sequences, in conjunction with
spectacular advances in mass spectrometric (MS) technology
for protein identiﬁcation have now made it possible to
quickly determine large numbers of proteins in complex mix-
tures (1–5). One early application of MS-based proteomics
has been the mapping of various proteomes—that is, the
identiﬁcation of their constituent proteins.
Partial proteomes of microorganisms have been reported,
for instance the malaria parasite proteome in various stages
of its life cycle (6,7) and international consortia are studying
the liver and brain proteome in mice and men. The proteomes
of body ﬂuids, such as the plasma proteome, the urinary
proteome and many others may have potential diagnostic
utility. The proteins expressed in speciﬁc cell types and cell
lines provide clues to functions of these cells and are useful
resource for researchers employing them as models. Finally,
‘organellar proteomes’ are the proteins constituting sub-
cellular structures such as mitochondria or non-membrane
enclosed structures such as the nucleolus (8,9).
Despite its obvious utility, proteome mapping faces several
technological and some conceptual challenges. Because of
the ﬁnite dynamic range and sequencing speed of MS, it is
difﬁcult to exhaustively map proteomes with the current
state of technology (10). Therefore, proteomes will remain
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(i.e. body ﬂuid proteomes change with the state of the organ-
ism), organellar proteomes vary between cell types (11) and
generally as a function of cell state (12). Biochemical
puriﬁcation of an organelle is never 100% successful, and
additional steps need to be incorporated into the proteomic
analysis to distinguish genuine members of the proteome
from co-purifying ones. For these and other reasons,
constructing databases of proteomes is not as straightforward
as constructing sequence databases and proteome databases
have to include much additional information concerning
the technology employed in mapping and the state of the
proteome. Of more immediate concern for proteome data-
base construction is the fact that MS technology can
mis-identify proteins, particularly when low-resolution tech-
nology is employed (2). Anderson et al. (13) have noted
that four studies of the blood plasma proteome identiﬁed
together 1175 proteins but only had an overlap of 4%
between them.
We have embarked on the mapping of a large number of
different proteomes. We employ high resolution mass spec-
trometry and peptide masses are typically measured within
a few p.p.m. Typically, proteins have to be identiﬁed with
at least two peptides, or peptides have to have been
sequenced by MS
3 [two subsequent stages of mass spec-
trometry, (14)]. Identiﬁed peptides generated by enzymatic
cleavage have to obey strict enzyme speciﬁcity. For our ref-
erence proteomes, criteria are chosen such that a search
against a nonsense database consisting of reversed sequence
entries (15) indicates error rates of less than one in a thou-
sand. Our goal is to eventually cover most important
organelles, cell types and tissues as well as body ﬂuids in
MAPU, accompanied by a set of uniﬁed analysis tools.
DATA GENERATION AND VALIDATION
Our typical work ﬂow to map a proteome is as follows
(Figure 1). Protein mixtures are obtained by homogenization
of tissue, centrifugation of a body ﬂuid, lysis of cultured cells
or sub-cellular fractionation. These mixtures are then
solubilized in SDS buffer and subjected to one dimensional
gel electrophoresis. 1D gels are Coomassie stained and cut
into 10–20 gel slices. These slices are in-gel digested
with trypsin or endoproteinase Lys-C and peptides are
extracted (16). Resulting peptide mixtures are automatically
loaded onto a 75 mm chromatography column and eluted
using a 2 h gradient. The MS platform used for nearly all
proteomes reported in MAPU is the linear ion trap—Fourier
transform ion cyclotron resonance mass spectrometer (LTQ-
FT ICR MS) or the linear ion trap—orbitrap (LTQ-Orbitrap).
Both instruments are manufactured by Thermo Electron and
are capable of extremely high mass accuracy (17,18) very
fast sequencing speeds and very high sensitivity. Several
hundred of the top scoring peptides are then used as internal
calibrants to remove any systematic mass errors by recalibrat-
ing all masses (7,10). Resolution of peptide spectra (termed
survey or MS
1 scans) is typically 50 000–100 000, which is
sufﬁcient to resolve nearly all co-eluting peptides. The n
most intense ions—with n typically 2–10 depending on the
complexity of the proteome—are fragmented and detected
in the linear ion trap, while the high resolution survey
spectrum is acquired in the FTICR or orbitrap part of the
instrument.
Data are processed and analyzed using an automated
pipeline involving peak recognition, database search with
the Mascot search engine (19), and optional manual valida-
tion using MSQuant, an open-source program developed by
our group and available at http://msquant.sourceforge.net.
Figure 1. Workflow for protein identification and validation.
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tein Index (IPI) database (20), which we ﬁnd to be an accept-
able compromise between inclusiveness (presence of most
protein coding sequences) and redundancy (several entries
for the same protein). Depending on the project, datasets
are joined and checked for overlap using ProteinCenter, a
proteomics software suite developed by Proxeon Biosystems
(http://www.proxeon.com). ProteinCenter also allows us to
directly distinguish which isoforms of a protein are present
in a proteome, provided that distinguishing peptide sequences
have been detected.
For proteins entered into a MAPU reference proteome,
very stringent identiﬁcation criteria are applied. It is not pos-
sible to ﬁx these criteria permanently for all projects because
technology is evolving rapidly, because different amounts of
manual validation are employed and because different pro-
jects deal with different proteome and database sizes. The fol-
lowing parameters are typical: (i) Peptides must have a length
of at least seven amino acids; (ii) mass accuracy after recali-
bration is typically better than 2 p.p.m. and no peptides with
mass deviation greater than 5 p.p.m. are allowed; (iii)
depending on the mass accuracy achieved and the complexity
of the proteome, different cut-offs for the Mascot peptide
database scores are required; (iv) we require that peptides
strictly obey enzymatic cleavage speciﬁcity (17). Generally,
at least two peptides are required for unambiguous protein
identiﬁcation. In addition to a minimum Mascot score for
each peptide, total protein identiﬁcation score is also required.
This minimum protein score is normally set so that a search
of a decoy database does not result in any hits. This assures
that the reported proteome contains no or very few false posi-
tives. Single peptide identiﬁcations are allowed only in
special cases, when supplementary information is available.
Currently, this supplementary information can be provided
by a second stage of peptide fragmentation (MS
3), by
a high resolution and high mass accuracy fragmentation spec-
trum recorded in the orbitrap or by the sequencing of SILAC
pairs [SILAC is a method employed in quantitative pro-
teomics and stands for Stable Isotope Labeling with Amino
acids in Cell culture, (21)]. MAPU also estimates a P-value
for the identiﬁcation for each protein where possible.
SUB-DATABASE ACCESS AND CONTENT
MAPU consists of several sub-databases containing different
proteomes. Common templates are used in creation of the
databases. All data are created in a single laboratory facilitat-
ing a common data standard, user interface and user experi-
ence. At the top level MAPU is organized into four
branches: body ﬂuids, tissues, cell types, and organelles.
Some of these branches contain a clickable map to access
the relevant proteomes.
Body fluid databases
Body ﬂuids are of special interest in proteomics because they
are an easily obtainable source of biomarkers. To discover
such biomarkers involves measurement of the proteomes of
healthy and diseased individuals and the construction of a
comprehensive protein catalog for each ﬂuid is a necessary
ﬁrst step. MAPU attempts to provide a ‘gold standard’ set
of reference proteomes for diagnostically important body
ﬂuid proteomes from normal individuals. So far, the follow-
ing human body ﬂuids have been analyzed by advanced pro-
teomics methods in our department: Plasma, urine,
cerebrospinal ﬂuid (CSF), tear ﬂuid, saliva, seminal ﬂuid
and breast milk.
Urinary proteome database
Urine is the second most important diagnostic body ﬂuid and
we performed an in depth analysis from healthy donors (22).
The MAPU urinary proteome database (http://www.
mapuproteome.com/urine) contains 1543 proteins measured
with extremely high conﬁdence, a much higher number
than all previous urinary proteome studies combined. Text-
book knowledge suggests that proteins of MW > 45 kDa
should be retained by the glomerular barrier in the kidney,
but we found many proteins with MW of >100 kDa. Further-
more, we found a large percentage of membrane proteins,
usually migrating at the apparent MW expected for the full
length protein. These proteins are probably present in urine
embedded in small vesicles. While this is the largest high
stringency body ﬂuid proteome to date, our previous model
study on the yeast proteome suggests that improved methods
should be able to at least double the number of proteins
detectable in urine in the future (10).
Tear fluid database
Recently, tear ﬂuid has become a subject of interest due to
several reports that demonstrate differences in protein content
in disease states such as diabetic dry-eye syndrome and Sjo-
gren’s syndrome (23–25). Tear ﬂuid was collected from a sin-
gle donor and analyzed in depth by MS
3 on an LTQ-FT
instrument and MS
2 on an LTQ-Orbitrap instrument (26).
Combined analysis resulted in the high conﬁdence identiﬁca-
tion of 491 proteins (http://www.mapuproteome.com/tear).
Notable features of this proteome are the high number of pro-
teins involved in protection against oxygen and pathogens.
Seminal fluid database
Seminal ﬂuid is a little studied but important body ﬂuid. It has
buffering properties and contains many distinct proteins,
contributing to the functioning and survival of spermatozoa
and is thus crucial to successful fertilization. The human semi-
nal ﬂuid proteome data may thus be useful in fertility related
research and may also be a starting point for future quanti-
tative analysis in diseases including prostate and testis can-
cer. We used LTQ-FTICR with MS
3 to identify a total of
923 proteins in seminal ﬂuid from a single individual (27).
The seminal ﬂuid database is located at http://www.
mapuproteome.com/seminal.
Milk database
Breast milk was collected from a human volunteer and sepa-
rated into water soluble, fat soluble and insoluble fractions
and each fraction analyzed by 1D gel electrophoresis fol-
lowed by MS (J.V. Olsen, G.M. Sowa et al. manuscript in
preparation). A total of more than 500 proteins were identi-
ﬁed. Apart from clinical use, this knowledge may be helpful
in designing infant formula.
Milk is the ﬁrst body ﬂuid proteome in which we have ana-
lyzed a post-translational modiﬁcation on a large scale. The
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enriched using titanium dioxide beads in the presence of
2,5-dihydroxy benzoic acid (DHB) according to a published
protocol (28). Many proteins were found to be phosphopro-
teins. This information is also contained in MAPU.
Cerebrospinal fluid database
Produced in amounts averaging 500 ml per day, CSF provides
buoyancy and protection to the brain and spinal cord. CSF
can be obtained by lumbar puncture and is the only readily
accessible ﬂuid in direct contact with the brain, carrying pro-
teins, protein fragments and regulatory peptides from per-
fused tissues. Consequently, there exists an enormous
interest in using CSF in diagnostics of neurodegenerative,
inﬂammatory, psychiatric and neoplastic disorders. We ana-
lyzed indepth a CSF sample of one person, and a CSF sample
pooled from ﬁve individuals. The MAPU CSF database
(http://www.mapuproteome.com/csf) contains 798 proteins
identiﬁed with near certainty in these samples (A. Zougmann,
B. Pilch et al., manuscript in preparation). We also character-
ized the low molecular weight range of the CSF proteome.
The ‘peptidome’ turned out to contain a number of known
and novel factors. The neuropeptides were investigated bioin-
formatically for the presence of characteristic features such
as N- and C-terminal pro-hormone enzymatic cleavage sites,
cysteine content, C-terminal amidation, and N-terminal
pyroglutamination. Several of the peptides were found to be
post-translationally modiﬁed by O-linked glycosylation and
phosphorylation.
Cell type and cell line database
The human body consists of more than 200 different cell types,
each with its distinct function, morphology and protein expres-
sion pattern. An example of a cell type represented in the
MAPUdatabaseistheredbloodcellproteomedescribedbelow.
Cell lines are the main experimental model of a large
community of researchers. These are cells originally isolated
from human donors or animals and subsequently transformed
or otherwise immortalized. They may serve as generic cells
(for example, HeLa cells are used to study basic cell biology
in microscopy studies), they are chosen for desirable experi-
mental attributes (HEK 293 cells for transfectability), or they
are selected to recapitulate essential aspects of the tissue of
interest (3T3-L1 mouse fat cells for adipose tissue or
HEPA 1-6 hepatocytes for the liver). It is important to
know which proteins are actually expressed in the model
cell employed. For example, when performing protein
interaction studies, only binding partners that are actually
expressed in the cell line can be found.
Human Red Blood Cell Database
The human Red Blood Cell Database (hRBCD, http://www.
mapuproteome.com/rbc) contains 587 proteins, divided into
membrane and soluble proteins (29). In additional, we also
provide information ranging from identiﬁcation of speciﬁc
isoforms to the class, metabolic status of identiﬁed proteins
and categorization by sub-cellular localization. MAPU sup-
plies information on the biochemical characteristics of the
membrane proteins and related statistical peptide information.
The hRBCD can be used in conﬁrming the presence of a
protein in the red blood cell and to obtain further information
on speciﬁc proteins and their biochemical behavior.
3T3-L1 cell line proteome database
We describe the proteome of a mouse fat cell line, 3T3-L1, as
an example of a cell line proteome. 3T3 L1 cells are adipo-
cyte precursors that are differentiated over the course of
eight days to adipocytes. They are the most common model
in adipocyte biology. In the Diabetes Genome Anatomy Pro-
ject, (http://www.diabetesgenome.org/) microarray studies
have already been performed. We fractionated differentiated
3T3-L1 cells into nuclear, microsomal (membrane), mito-
chondrial and cytosolic fractions and analyzed each of them
by ‘GeLCMS’. Together we found more than 3287 unique
proteins (J. Adachi, C. Kumar et al. submitted) (http://
www.mapuproteome.com/adipo). From this and the microar-
ray information we conclude that the fat cell proteome is
likely to have a very complex proteome of more than 5000 dif-
ferent proteins. This is a further indication that fat cells are
not just passive storage container for lipids but participate in
a network of complex regulatory functions.
Organellar proteomes
The eukaryotic cell has a sophisticated sub-cellular organiza-
tion, which is a main subject of cell biology. Best known are
the membrane-enclosed organelles in the cytoplasma: Golgi
apparatus, endoplasmic reticulum, mitochondria and others.
The nucleus also has organelles but the mechanisms for
maintaining their organization are less clear. We have previ-
ously described the mouse mitochondrial proteome in various
tissues (11). Furthermore,—in collaboration with the Angus
Lamond laboratory—we have characterized the human
nucleolar proteome. These data are already accessible in the
nucleolar database at http://www.lamondlab.com/nopdb/
(12,30).
Organellar databases—and other proteome databases to a
lesser degree—have another source of erroneous identiﬁca-
tion besides the potential for misidentiﬁcation by MS. Even
when the protein is correctly determined by MS, it may just
have been co-purifying in the organellar preparations and
may not be a genuine member of the organellar proteome.
When determining the proteome of the centrosome, the
microtubule organizing center of animal cells and a structure
involved in chromosome segregation, we distinguished cen-
trosomal proteins from co-purifying ones using an algorithm
called Protein Correlation Proﬁling (PCP), in which the sedi-
mentation proﬁle of an organellar protein distinguishes it
from unrelated ‘background’ proteins (31). We brieﬂy
describe the Organellar Map Database (ORMD) in the next
section, a part of MAPU that contains the results of applying
the same principle to all membrane enclosed organelles in
mouse liver tissue.
Organellar Map Database
Protein localization to membrane-enclosed organelles is a
central feature of cellular organization. Using a linear ion-
trap Fourier transform mass spectrometer (LTQ-FTICR MS,
Thermo Finnigan) combined with the PCP method (31), we
identiﬁed 2197 proteins in mouse liver homogenate (32).
Peptides identifying these proteins were quantiﬁed over 32
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apparent in the data and over 1400 proteins were mapped
to them (32). The ORMD (http://www.mapuproteome.com/
ormd/) lists all the identiﬁed proteins with their sub-cellular
localization. ORMD presents basic information for the
identiﬁed mouse liver proteins. (i) protein name, IPI acces-
sion, Uniprot accession and protein description, (ii) sub-
cellular locations of proteins, (iii) information of identiﬁed
peptides which support proteins, including peptide sequence,
peptide delta score, location on proteins, (iv) a link of the
protein to the IPI and Uniprot (33) databases. As in the
other databases, homology search is supported using protein
sequences by a BLAST module (34). The user may upload
an IPI accession list to do a batch search and obtain all
relevant information in the ORMD database. ORMD
currently archives 2197 proteins in total.
Interestingly, 39% of all proteins with localization infor-
mation belong to more than one organelle. Data in ORMD
comes from endogenous proteins in tissue and therefore is a
good complement to localization information obtained by
overexpressed ﬂuorescent fusion proteins in cell lines. Infor-
mation in ORMD has also been transferred to the MINT
(a)
(b)
Figure 2. Four search facilities in the MAPU database. (a) Search sections in ORMD. At the top of the section, there is a button ‘List all data’ for list-query. The
left side is the advanced search query section, which includes several search terms. Some of these are specific to different sub-databases. The right side is
so-called batch search module, but only in ORMD. The bottom of search section is BLAST search section. The input protein sequence should be in fasta format
and E-value is 1e10. (b) Cell sub-cellular map in ORMD. The picture is clickable and presents sub-cellular location name when the mouse is moving over them.
We also list all selectable sub-cellular locations in ORMD on the right side. User can also click them directly to go to the protein list report. The same idea will be
applied to other sub-databases, such as body fluid database, in the future.
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and genomic data enabled identiﬁcation of networks of co-
expressed genes, cis-regulatory motifs, and putative transcrip-
tional regulators involved in organelle biogenesis (11,32,36).
Large-scale sub-cellular proteomics thus ties biochemistry,
cell biology and genomics into a common framework for
organelle analysis.
WEB QUERY/SEARCH INTERFACE
We strove to develop search interfaces that are sufﬁciently
ﬂexible to handle the different sub-databases, allow easy
retrieval of information and—as much as possible—enforce
a common user interface across the databases. MAPU
provides four search facilities (Figure 2): list-query button,
advanced search query section, BLAST search section,
and clickable ﬁgure-mapped search section. Usually queries
are performed in the sub-databases but a common search
interface for all MAPU databases and for each of the four
main branches will also be provided.
List-query button
At the top of each search section, we provide quick access to
all of the proteome data in the database, using a button
termed ‘List all data’. This operation retrieves all identiﬁed
proteins with relevant information for each individual
database in a protein list report page. This simple module
provides access to all the data for integrative bioinformatic
analysis by other researchers.
Advanced search query section
The sub-databases differ in terms of the type of data and they
support project-depended information. We provide advanced
search query sections with the information that the proteome
data have as the search terms (Figure 2a). Thus specialized
query interfaces have been built for different databases with
commonly-used search terms. (e.g. IPI accession number
and protein name, particularly with protein description, pep-
tide sequence in the seminal ﬂuid database, biochemical
methods and sub-cellular localization in the red blood cell
database, and UniProt accession number, sub-cellular loca-
tion in ORMD.) In ORMD, we also provide a batch search
module (Figure 2a). Users can use this module to retrieve a
protein list report page with a series of IPI accession num-
bers. Two report pages are implemented: protein list report
and peptide list report (Figure 3). All protein IPI accession
numbers (and UniProt accession numbers) have been linked
to IPI (and UniProt) database so that users can obtain more
Figure 3. Report pages in the MAPU database. Protein list report page (in ORMD, Seminal fluid Database and Red Blood Cell Database). All proteins in our
proteome database are hyperlinked in the BLAST result page. User can navigate to the protein report in the relevant sub database using these hyperlinks.
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seminal ﬂuid database, the protein list report page contains
protein IPI accession, Swissprot accession, gene symbol,
molecular weight, number of identiﬁed peptides and tissue
name; the peptide list report page contains peptide sequence,
modiﬁcation, MS
2 score, MS
2 + MS
3 score, MS
3 precursor,
peptide length, and delta mass (difference between calculated
and measured mass in p.p.m.). In the red blood cell database,
the protein list report page contains protein IPI accession,
protein name, protein description, protein category, bio-
chemical methods, sub-cellular location and some other rele-
vant information. In ORMD, the protein list report page
contains IPI accession, UniProt accession, protein name,
protein description, sub-cellular location, number of identi-
ﬁed peptides and related information. The peptide list report
page shows peptide sequence and peptide score, and associ-
ated proteins with relevant protein information, such as
protein IPI accession, UniProt accession, name, length,
description, sub-cellular location. The peptide position in
the proteins is also displayed.
BLAST search section
The protein sequences can be searched via BLAST (Figure 2a)
to identify sequence similarities between user-submitted
sequences and the protein sequences in MAPU (E-value
1e10). For user friendliness, all proteins in our proteome
database are hyperlinked in the BLAST result report.
Clickable figure-mapped search section
In the ORMD database, we have a picture of a generic cell
and users can directly click different sub-cellular locations
to search proteins located there (Figure 2b).
SYSTEM DESIGN AND IMPLEMENTATION
The MAPU database adopts the popular Browser/Server
model and consists of a database server and an application
server. The application system is based on the open source
MySQL relational database and runs on the open source
Tomcat application server. JSP and Java Bean are served as
client requests.
We also developed some common templates that can be
used for generating branch databases. For example, the
common search module and the BLAST search module are
implemented from templates. With a view to increase search
performance, we created different instances for different data-
bases, and indexes on some search parameters. We also
implemented scripts to obtain statistics from all branch data-
bases.
The data work ﬂow in the MAPU database is illustrated in
Figure 4. A database specialist (Y.Z.) and the proteomics res-
earchers that create the original data agree on a set of data
items to be reported in the database. This information is used
to create formats that are kept as similar as possible across
projects. Dataset parsers are then created to extract the rele-
vant information from those datasets and automatically
upload them to the database. All of the above searches func-
tionalities give users a protein report with detail information.
In most protein list report pages, the item ‘number of identi-
ﬁed peptides’ is linked to the peptide list report with details.
PERSPECTIVE
We have created a family of proteome databases, which we
hope will become an important resource for biology and
biomedicine. We chose to integrate only our own data to
escape the error accumulation effect currently seen in the
Figure 4. Data work flow in our MAPU database. To generate the branches
databases more easily and flexibly, we developed dataset parsers/database
generators as assistant tools. The whole work flow is from original data to
data in database with several functional modules by our parser, generator
tools and common templates.
Nucleic Acids Research, 2007, Vol. 35, Database issue D777proteomic literature. Our data can be freely downloaded and
incorporated into more universal databases such as UniProt
and SwissProt, as long as their source is acknowledged. Simi-
larly, some of the data has already been uploaded into the
MINT database and dedicated proteomics databases such as
PeptideAtlas (37) and PRIDE (38)
The next version of the MAPU database will (i) include
more body ﬂuid proteomes and cell line proteomes (ii) have
comparative analysis, summary and difference between dif-
ferent body ﬂuid samples, e.g. GO-categories distribution
and comparison (39,40), (iii) incorporate more complex
annotation information for each protein from other informa-
tive database, (iv) integrate more powerful search modules,
(v) provide a platform for user to compare their own data
with our public proteome data, (vi) alternatively, if necessary,
combine relevant genome information as a reference. In sum-
mary, the MAPU database provides a powerful and user
friendly resource for scientists to explore the proteome.
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